In conclusion, uPAR-specific CAR T cells and ARMs are promising immunotherapies that not only block the uPA/uPAR interaction, but also achieve immune-mediated cell death by targeting uPAR-expressing tumour cells [222]. Here, PLAUR is linked to neoplasm.